Endo Operations patent expiration

1. Adrenalin patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9295657 ENDO OPERATIONS Epinephrine formulations
Mar, 2035

(10 years from now)

US10130592 ENDO OPERATIONS Epinephrine formulations
Mar, 2035

(10 years from now)

US9119876 ENDO OPERATIONS Epinephrine formulations
Mar, 2035

(10 years from now)

US11083698 ENDO OPERATIONS Epinephrine compositions and containers
Mar, 2039

(14 years from now)

US11207280 ENDO OPERATIONS Epinephrine compositions and containers
Mar, 2039

(14 years from now)

US10653646 ENDO OPERATIONS Epinephrine compositions and containers
Mar, 2039

(14 years from now)




Drugs and Companies using EPINEPHRINE ingredient

Market Authorisation Date: 18 December, 2013

Treatment: Emergency treatment of allergic reactions (type i), including anaphylaxis; To increase mean arterial blood pressure in adult patients with hypotension associated with septic shock

Dosage: SOLUTION

How can I launch a generic of ADRENALIN before it's drug patent expiration?
More Information on Dosage

ADRENALIN family patents

Family Patents

2. Aveed patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7718640 ENDO OPERATIONS Methods and pharmaceutical compositions for reliable achievement of acceptable serum testosterone levels
Mar, 2027

(2 years from now)

US8338395 ENDO OPERATIONS Methods and pharmaceutical compositions for reliable achievement of acceptable serum testosterone levels
May, 2027

(2 years from now)




Drug Exclusivity Drug Exclusivity Expiration
New Product(NP) Mar 05, 2017

Drugs and Companies using TESTOSTERONE UNDECANOATE ingredient

Market Authorisation Date: 05 March, 2014

Treatment: Testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone; Primary hypogonadism (congenital or acquired); Hypogonadotropic hypog...

Dosage: INJECTABLE

How can I launch a generic of AVEED before it's drug patent expiration?
More Information on Dosage

AVEED family patents

Family Patents

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

3. Ephedrine Sulfate patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10869845 ENDO OPERATIONS Ephedrine compositions and methods
Jan, 2040

(15 years from now)




Drugs and Companies using EPHEDRINE SULFATE ingredient

Market Authorisation Date: 22 April, 2022

Treatment: NA

Dosage: SOLUTION

How can I launch a generic of EPHEDRINE SULFATE before it's drug patent expiration?
More Information on Dosage

EPHEDRINE SULFATE family patents

Family Patents

4. Fortesta patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6579865 ENDO OPERATIONS Penetration enhancing and irritation reducing systems
Nov, 2018

(5 years ago)

US6319913 ENDO OPERATIONS Penetration enhancing and irritation reducing systems
Nov, 2018

(5 years ago)




Drug Exclusivity Drug Exclusivity Expiration
New Product(NP) Dec 29, 2013

Drugs and Companies using TESTOSTERONE ingredient

Market Authorisation Date: 29 December, 2010

Treatment: Testosterone replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone

Dosage: GEL, METERED

How can I launch a generic of FORTESTA before it's drug patent expiration?
More Information on Dosage

FORTESTA family patents

Family Patents

5. Frova patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5962501 ENDO OPERATIONS Enantiomer of carbazole derivative as 5-HT1-like agonists
Dec, 2013

(10 years ago)

US5616603 ENDO OPERATIONS Enantiomers of carbazole derivatives as 5-HT1 -like agonists
Apr, 2014

(10 years ago)

US5637611 ENDO OPERATIONS Medicaments
Jun, 2014

(10 years ago)

US5827871 ENDO OPERATIONS Medicaments 1,2,3,4-tetrahydrocarbazoles and 5-HT1 agonist use thereof
Oct, 2015

(8 years ago)

US5464864 ENDO OPERATIONS Use of tetrahydrocarbazone derivatives as 5HT1 receptor agonists
Nov, 2015

(8 years ago)




Drugs and Companies using FROVATRIPTAN SUCCINATE ingredient

Market Authorisation Date: 08 November, 2001

Treatment: Acute treatment of migraine attacks with or without aura in adults

Dosage: TABLET

How can I launch a generic of FROVA before it's drug patent expiration?
More Information on Dosage

FROVA family patents

Family Patents

6. Supprelin La patent expiration

SUPPRELIN LA's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8062652 ENDO OPERATIONS Compositions and methods for treating precocious puberty
Jun, 2026

(1 year, 10 months from now)




Drug Exclusivity Drug Exclusivity Expiration
Orphan Drug Exclusivity(ODE) May 03, 2014

Drugs and Companies using HISTRELIN ACETATE ingredient

Market Authorisation Date: 03 May, 2007

Treatment: Method of treatment of children with central precocious puberty

Dosage: IMPLANT

More Information on Dosage

SUPPRELIN LA family patents

Family Patents

7. Testim patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7608607 ENDO OPERATIONS Pharmaceutical composition
Apr, 2023

(1 year, 2 months ago)

US7608609 ENDO OPERATIONS Pharmaceutical composition
Apr, 2023

(1 year, 2 months ago)

US8063029 ENDO OPERATIONS Pharmaceutical composition
Apr, 2023

(1 year, 2 months ago)

US8178518 ENDO OPERATIONS Pharmaceutical composition
Apr, 2023

(1 year, 2 months ago)

US7935690 ENDO OPERATIONS Pharmaceutical composition
Apr, 2023

(1 year, 2 months ago)

US7608605 ENDO OPERATIONS Pharmaceutical composition
Apr, 2023

(1 year, 2 months ago)

US7608608 ENDO OPERATIONS Pharmaceutical composition
Apr, 2023

(1 year, 2 months ago)

US7608606 ENDO OPERATIONS Pharmaceutical composition
Apr, 2023

(1 year, 2 months ago)

US7608610 ENDO OPERATIONS Pharmaceutical composition
Apr, 2023

(1 year, 2 months ago)

US7320968 ENDO OPERATIONS Pharmaceutical composition
Jan, 2025

(6 months from now)




Drugs and Companies using TESTOSTERONE ingredient

Market Authorisation Date: 31 October, 2002

Treatment: Method for administration of testosterone

Dosage: GEL

How can I launch a generic of TESTIM before it's drug patent expiration?
More Information on Dosage

TESTIM family patents

Family Patents

8. Vasostrict patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10010575 ENDO OPERATIONS Vasopressin formulations for use in treatment of hypotension
Jan, 2035

(10 years from now)

US9974827 ENDO OPERATIONS Vasopressin formulations for use in treatment of hypotension
Jan, 2035

(10 years from now)

US9968649 ENDO OPERATIONS Vasopressin formulations for use in treatment of hypotension
Jan, 2035

(10 years from now)

US9962422 ENDO OPERATIONS Vasopressin formulations for use in treatment of hypotension
Jan, 2035

(10 years from now)

US9925234 ENDO OPERATIONS Vasopressin formulations for use in treatment of hypotension
Jan, 2035

(10 years from now)

US9981006 ENDO OPERATIONS Vasopressin formulations for use in treatment of hypotension
Jan, 2035

(10 years from now)

US9919026 ENDO OPERATIONS Vasopressin formulations for use in treatment of hypotension
Jan, 2035

(10 years from now)

US9375478 ENDO OPERATIONS Vasopressin formulations for use in treatment of hypotension
Jan, 2035

(10 years from now)

US9744239 ENDO OPERATIONS Vasopressin formulations for use in treatment of hypotension
Jan, 2035

(10 years from now)

US9925233 ENDO OPERATIONS Vasopressin formulations for use in treatment of hypotension
Jan, 2035

(10 years from now)

US9744209 ENDO OPERATIONS Vasopressin formulations for use in treatment of hypotension
Jan, 2035

(10 years from now)

US9687526 ENDO OPERATIONS Vasopressin formulations for use in treatment of hypotension
Jan, 2035

(10 years from now)

US9750785 ENDO OPERATIONS Vasopressin formulations for use in treatment of hypotension
Jan, 2035

(10 years from now)

US9937223 ENDO OPERATIONS Vasopressin formulations for use in treatment of hypotension
Jan, 2035

(10 years from now)




Drugs and Companies using VASOPRESSIN ingredient

Market Authorisation Date: 17 April, 2014

Treatment: To increase blood pressure in adults with vasodilatory shock (e.g., post-cardiotomy or sepsis) who remain hypotensive despite fluids and catecholamines

Dosage: SOLUTION

How can I launch a generic of VASOSTRICT before it's drug patent expiration?
More Information on Dosage

VASOSTRICT family patents

Family Patents